Nestle divests peanut allergy business Palforzia

Capsules of Palforzia are shown containing pharmaceutical grade peanut powder, for use in oral immunotherapy among patients with peanut allergies, manufactured by Aimmune Therapeutics, based in Brisbane, California, in this handout obtained on February 5, 2020. Aimmune Therapeutics/Handout via…#palforzia #aimmunetherapeutics #brisbane #nestle
Source: Reuters: Health - Category: Consumer Health News Source Type: news